PPPC/EUGT/ITPS workshop on clinical validation and utility of susceptibility genetic testing

Monday, October 8, 2007

Session 1 (at the hotel) 6-7pm

Chairperson: Ulf Kristoffersson

18,00   Welcome address and housekeeping issues (Dolores Ibarreta, Martina Cornel, Ulf Kristoffersson, Jörg Schmidtke, Eleni Zita)

18,15-19,00     The public and genetic testing: Ensuring confidence in medical genetic testing (Helen Wallace (Gene Watch))

19.15   Get together with a tapas meal either at the hotel or a nearby restaurant

Tuesday, October 9, 2007

Session 2

Chairperson: Jörg Schmidtke

9,00     Goals and possibilities of genetic testing for common/complex diseases (Michel Krawszak) (30min+discussion)

10,45   Pros and cons of susceptibility testing, (4 examples, 15 min each):

            Coffee break included

• Cancer (breast cancer both rare and susceptibility genetic testing available) (Shirley Hodgson)
• Coagulation disorders (Thrombophilia) (Björn Dahlbäck)
• Cardiac disorders (Irene van Langen)
• Psychiatric diseases (Claus Lesch)

11,30   Economic costs and benefits of susceptibility testing (Wolf Rogowski) (30min+discussion)

12,00   Public health and susceptibility genetic testing (Tony Holzman)

12,45    Patients organisations view on susceptibility testing (Alastair Kent) (30min+discussion)

13,30   Lunch

Session 3

Chair: Martina Cornel

14,30   Group discussions (including coffee/tea break)

                        Each group consists of 6-8 persons. A chair is appointed by the management; each group appoints a raporteur.

16,15   Reports from groups and global discussion

17,45   Summarising the day  (Jörg Schmidtke, Martina Cornel)

18,00   End of day 1

20,30   Conference dinner on a restaurant selected by the local organisers

Wednesday, October 10, 2007

Session 4

Chair: Dolores Ibarreta

9,00     Clinical utility anad regulatory frameworks

• EMEA (Marisa Papaluca Amati)
• FDA (Felix Fruch)
• EGGAP/CDC (Linda Bradley)
• DG ENTR; IVD-directive (John Brennen)

11,00            Group Discussion

12.15            Group reports

13,00            Final discussion and closing remarks (Jörg Schmidtke, Martina Cornel, Dolores Ibareta)

13,30            End of meeting

13.30   Lunch for PPPC, and those others who want

14,00   PPPC - meeting